These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1537139)

  • 1. Intravesical recombinant tissue plasminogen activator for the prevention of implantation-mediated bladder tumor recurrence.
    See WA
    Clin Exp Metastasis; 1992 Mar; 10(2):99-109. PubMed ID: 1537139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of transitional tumor cell adherence to sites of urothelial injury in rats: mechanisms mediating intravesical recurrence due to implantation.
    See WA; Miller JS; Williams RD
    Cancer Res; 1989 Oct; 49(19):5414-8. PubMed ID: 2766306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activators: regulators of tumor cell adherence to sites of lower urinary tract surgical trauma.
    See WA
    J Urol; 1993 Sep; 150(3):1024-9. PubMed ID: 8345579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin prevention of tumor cell adherence and implantation on injured urothelial surfaces.
    See WA; Chapman PH
    J Urol; 1987 Jul; 138(1):182-6. PubMed ID: 2955131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
    Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
    Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of transitional tumor cell line 4909 adherence to injured urothelial surfaces in F-344 rats.
    See WA; Chapman PH; Williams RD
    Cancer Res; 1990 Apr; 50(8):2499-504. PubMed ID: 2317832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose cyclophosphamide for the prevention of bladder tumor implantation in F344 rats: site of drug activity.
    See WA; Crist SA; Williams RD
    Cancer Res; 1991 Mar; 51(5):1378-83. PubMed ID: 1997176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS; Jordan AM; Murphy WM
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose preoperative systemic cyclophosphamide for the prevention of bladder tumor implantation in F344 rats.
    See WA; Crist SA; Boileau MA; Williams RD
    Cancer Res; 1991 Mar; 51(5):1373-7. PubMed ID: 1997175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
    Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
    Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model.
    van Goor H; Bom VJ; van der Meer J; Sluiter WJ; Geerards S; van der Schaaf W; de Graaf JS; Bleichrodt RP
    Eur Surg Res; 1996; 28(4):287-94. PubMed ID: 8813653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS; Slocum HK; Rustum YM; Greco WR; Gaeta JF; Huben RP
    J Urol; 1989 Dec; 142(6):1589-93. PubMed ID: 2511340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical suramin in the prevention of transitional cell carcinoma.
    Graham SD; Napalkov P; Oladele A; Keane TE; Petros JA; Clarke HS; Kassabian VS; Dillehay DL
    Urology; 1995 Jan; 45(1):59-63. PubMed ID: 7817482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion.
    Deng J; Mei H; Shi W; Pang ZQ; Zhang B; Guo T; Wang HF; Jiang XG; Hu Y
    Curr Med Sci; 2018 Jun; 38(3):427-435. PubMed ID: 30074208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function.
    Gautier S; Petrault O; Gele P; Laprais M; Bastide M; Bauters A; Deplanque D; Jude B; Caron J; Bordet R
    Stroke; 2003 Dec; 34(12):2975-9. PubMed ID: 14615621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial with intravesical alfa-2b interferon for the prevention of T1 transitional carcinoma of the bladder: preliminary results. Review of the bibliography].
    Portillo Martín JA; Martín García B; Hernández Rodríguez R; Correas Gómez MA; Gutiérrez Baños JL; del Valle Schaan JI; Monge Mirallas JM; Roca Edreira A
    Arch Esp Urol; 1995 Jun; 48(5):479-88. PubMed ID: 7639570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity.
    See WA; Xia Q
    J Natl Cancer Inst; 1992 Apr; 84(7):510-5. PubMed ID: 1545441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.